期刊文献+

口咽鳞状细胞癌患者治疗及预后因素分析 被引量:5

Treatments and prognosis of patients with squamous cell carcinoma of the oropharynx
下载PDF
导出
摘要 目的探讨口咽鳞状细胞癌(简称鳞癌)以手术为主和以放疗为主的两种治疗方式疗效及影响预后的因素。方法回顾性分析我院自1985年3月~2005年10月期间收治的239例病理确诊的口咽鳞癌患者的临床资料,其中173例行单纯放疗或放疗加挽救性手术,66例行单纯手术或手术加放疗。Ⅰ期患者15例,Ⅱ期45例,Ⅲ期71例,Ⅳ期108例。生存分析采用Kaplan-Meier法及Log rank检验,多因素分析采用Cox回归模型法。结果两治疗组患者3年总生存率分别为54.5%和52%,5年总生存率分别为44.9%和43.8%,两种治疗方法患者生存率差异无统计学意义(P>0.05)。I~IV期患者3年生存率分别为73.3%、70.4%、54.2%和41.3%,5年生存率分别为66%、63.1%、47.6%和30.5%。多因素分析显示临床分期、T分级、有无淋巴结转移是主要的预后影响因素。结论两种治疗方法对口咽鳞癌患者的预后相当,临床分期、T分级、有无淋巴结转移是主要的预后影响因素。 OBJECTIVE To evaluate the therapeutic outcomes of mainly-surgery or mainly-radiotherapy treatment and define the prognostic factors in patients with squamous cell carcinoma(SCC)of the oropharynx.METHODS From March 1985 to October 2005,239 patients with SCC of the oropharynx proved pathologically were eligible for the present study.One hundred and seventy three of them were treated with radiotherapy followed surgery or not(RT±S),while 66 of them were treated with surgery followed radiotherapy or not(S± RT).According to TNM staging system,there were 15 patents in stage I,45 in stage Ⅱ,71 in stage Ⅲ,108 in stage IV.Kaplan-Meier and Logrank tests were used for survival analysis,while Cox stepwise regression model was used for multivariate analysis of prognostic factors.RESULTS The 3-year survival rates in two treatment group were 54.5% and 52% respectively and the 5-year survival rates were 44.9% and 43.8% respectively.Difference of survival rates between the two groups was not statistically significant.The 3-year survival rates based on stage were 73.3% for stage I,70.4% for stage Ⅱ,54.2% for stage Ⅲ,41.3% for stage IV.The 5-year survival rates based on stage were 66.0% for stage I,63.1% for stage Ⅱ,47.6% for stage Ⅲ,30.5% for stage IV.Multivariate analysis showed that AJCC stage,tumor stage and nodal stage were the significant prognostic factors.CONCLUSION The survival rates of patients in two treatment groups were not statistically different.AJCC stage,primary tumor and nodal stage were the signi?cant prognostic factors.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2011年第6期284-287,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 口咽肿瘤 外科手术 放射疗法 预后 Oropharyngeal Neoplasms Surgical Procedures Operative Radiotherapy Prognosis
  • 相关文献

参考文献13

  • 1Jackson RM, Rice DH. Blood transfusions and recurrence in head and neck cancer. Ann Otol Rhinol Laryngol, 1989, 98: 171-173.
  • 2Watkinson JC, Owen C, Thompson S, et al. Conservation surgery in the management of T1 and T2 oropharyngeal squamous cell carcinoma: the Birmingham UK experience. Clin OtolaryngolAllied Sci, 2002, 27: 541-548.
  • 3Foote RL, Schild SE, Thompson WM, et al. Tonsil cancer. Patterns of faliure after surgery alone and surgery combined with postoperative radiation therapy. Cancer, 1994, 73: 2638-2647.
  • 4Hicks WL Jr, Kuriakose MA, Loree TR, et al. Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991) . Laryngoscope, 1998, 108: 1014-1019.
  • 5Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer, 2002, 94: 2967-2980.
  • 6Van den Bogaert W, Van der Schueren E, Horiot JC, et al. The EORTC randomized trial on three fractions per day and misonidazole (trial no.22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol, 1995, 35: 91-99.
  • 7Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience.Int J Radiat Oncol Biol Phys, 1996, 34: 289-296.
  • 8Becker M. Oral cavity, oropharynx, and hypopharynx. Semin Roentgenol, 2000, 35: 21-30.
  • 9Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx--an analysis of treatment results in 289 consecutive patients. Acta Oncol, 2000, 39: 985-994.
  • 10Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-time therapy outcome. Int J Radiat Oncol Biol Phys, 1998, 42: 1077-1084.

同被引文献28

  • 1张彬,李德志,徐震纲,唐平章.游离股前外侧皮瓣修复头颈肿瘤术后缺损[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):447-450. 被引量:20
  • 2王烈,杨小湜,侯哲,冯巧莲,丸井英二.护理者负担量表中文版的应用与评价[J].中国公共卫生,2006,22(8):970-972. 被引量:549
  • 3付玉贵,彭解人,黄晓明,蔡翔,龚坚.胸大肌肌皮瓣在鼻咽癌放疗后颈部挽救性手术中的应用[J].中国耳鼻咽喉颅底外科杂志,2006,12(4):265-267. 被引量:6
  • 4Broglie M A,Soltermann A,Haile SR,et al.Quality of life oforopharyngeal cancer patients with respect to treatment strate-gy and p16-positivity[J].Laryngoscope,2013,123(1):164.
  • 5Loewenthal M,Vitez E,Laban S,et al.New aspects of cur-rent therapeutic strategies in oropharyngeal carcinoma:high-lights of the 2012 ASCO meeting[J].HNO,2012,60(11):951.
  • 6Adelstein D J,Ridge J A,Brizel D M,et al.Transoral resec-tion of pharyngeal cancer:summary ofa National Cancer Inst-itute Head and Neck Cancer Steering Committee Clinical TrialsPlanning Meeting,November 6-7,2011,Arlington,Vir-ginia[J].Head Neck,2012,34(12):1681.
  • 7Vikulova IuV.The state-of-the-art of the diagnosis of o-ral and oropharyngeal cancer[J].Vestn Rentgenol Radiol,2012,(3):51.
  • 8Perisanidis C,Sulzbacher I,Mittlb ck M,et al.Survival ofpatients with pathologic T0N+oral and oropharyngeal cancerafter neoadjuvant therapy and surgery:the minority report[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2013,115(3):293.
  • 9Haughey B H,Sinha P.Prognostic factors and survival uniqueto surgically treated p16+oropharyngeal cancer[J].Laryngo-scope,2012,122(Suppl 2):S13.
  • 10Wu Y,Posner M R,Schumaker L M,et al.Novel biomarkerpanel predicts prognosis in human papillomavirus-negativeoropharyngeal cancer:an analysis of the TAX 324 trial[J].Cancer,2012,118(7):1811.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部